Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Feb 1, 2016
Emerging Company Profile
Degradation by Degronimid
...Number of employees: Not disclosed Funds raised: $73 million Investors: Cobro Ventures, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
Jan 11, 2016
Finance
Dollars for degradation
...of C4. Cobro led the round, with participation from Cormorant Asset Management, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
Jan 11, 2016
Financial News
C4 Therapeutics completes venture financing
...Type: Venture financing Raised: $73 million Investors: Cobro Ventures; Cormorant Asset Management; The Kraft Group;
EG Capital
...
Read More
BioCentury
|
Jan 8, 2016
Financial News
C4 debuts with $73M, Roche deal
...platform while Dana-Farber was developing it. Other investors included Cormorant Asset Management, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
May 4, 2007
Financial News
Progen planning financings
...5.9 million PGL shares at A$5.74 in a rights issue underwritten by Bell Potter and
eG Capital
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Feb 1, 2016
Emerging Company Profile
Degradation by Degronimid
...Number of employees: Not disclosed Funds raised: $73 million Investors: Cobro Ventures, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
Jan 11, 2016
Finance
Dollars for degradation
...of C4. Cobro led the round, with participation from Cormorant Asset Management, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
Jan 11, 2016
Financial News
C4 Therapeutics completes venture financing
...Type: Venture financing Raised: $73 million Investors: Cobro Ventures; Cormorant Asset Management; The Kraft Group;
EG Capital
...
Read More
BioCentury
|
Jan 8, 2016
Financial News
C4 debuts with $73M, Roche deal
...platform while Dana-Farber was developing it. Other investors included Cormorant Asset Management, The Kraft Group,
EG Capital
...
Read More
BioCentury
|
May 4, 2007
Financial News
Progen planning financings
...5.9 million PGL shares at A$5.74 in a rights issue underwritten by Bell Potter and
eG Capital
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page